ERBB3 and neoplasm: Furthermore, 89Zr-GSK2849330 could be used diagnostically to differentiate tumor lesions expressing HER3 and monitor the response to treatment in patients with metastatic cancer by measuring the drug uptake in the different tumor lesions thereby addressing variability between patients, within patients and within lesions.